Tag Archives: cancer

Developing Cancer Therapies and Diagnostics: 4 Pieces of Advice

oncology

Insights in to the molecular and genetic basis of disease are driving new product and therapeutic opportunities while changing the treatment paradigm for many cancers. The use of companion diagnostics in oncology may play a role in optimizing and expediting the development of targeted therapies for many cancers and other conditions. Focusing on these new markets, a panel of industry executives and investors at the 2011 BIO Investor Forum discussed some of the most compelling Read More >

Health  |  1 Comment  |  Email This Post
Tags: , , , , , , ,

BIO Investor Forum Company Snapshot: Immune Design

immunedesign

In the third installment of the Investor Forum Company Snapshots, hear from Immune Design Corp. The CEO of the company, Dr. Carlos Paya, will be presenting next week at the 10th Annual BIO Investor Forum on Tuesday afternoon. Company Snapshot What are the short-term and long-term priorities for your company? Short term: focus on validating in patients a product from each of our two novel technologies.  We will be conducting testing of : 1) An Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Confessions of a Cancer-Free Cancer Patient

Sandra Dennis

By Sandra Dennis, Deputy General Counsel for Healthcare, the Biotechnology Industry Organization October is breast cancer awareness month. As a dear friend said to me recently — it’s a whole month? She also despises the whole pink ribbon thing. I didn’t dare mention to her that there’s a breast cancer stamp. While it could suggest a lack of empathy, she was treated for breast cancer several years ago, so she speaks from the perspective of Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , ,

Biotechnology Delivers Medical Discoveries to Benefit Women Facing Breast Cancer

Marc S. Hurlbert

By Marc S. Hurlbert, Ph.D., Executive Director, Avon Foundation Breast Cancer Crusade The field of breast cancer has witnessed remarkable progress due to dedicated biotechnology and academic scientists, advocates, patients, nurses and physicians. Sixty years ago, a woman diagnosed with early stage breast cancer had less than a 55 percent chance of living 10 years, while today those odds are greater than 85 percent. We have made great advances in detecting cancer early with imaging including Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , ,

BIO Investor Forum Company Snapshot: Syndax Pharmaceuticals

Syndax

Next up in our Company Snapshot segment for the BIO Investor Forum is another presenting company of the event. Hear from Joanna Horobin, President & CEO of Syndax Pharmaceuticals, Inc. Company Snapshot What are the short-term and long-term priorities for your company? Near-term we are focused on moving our lead product candidate, entinostat, in to a phase 3 clinical trial for post-menopausal women with estrogen receptor-positive (ER+) metastatic breast cancer (MBC). Long-term our goal is Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , , , ,